Using liraglutide to prevent delirium in elderly diabetic patients after heart surgery
Official title: Perioperative Application of Liraglutide for the Prevention of Postoperative Delirium Among Elderly Patients with Type 2 Diabetes Undergoing Cardiac Surgery: a Single-Center Randomized Controlled Study
Run by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · NCT06361238 · Data updated 2026-11-12
This study is testing if liraglutide can help prevent confusion after heart surgery in older diabetic patients.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 260 (estimated) |
| Sponsor | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Academic / other |
| Locations | 1 site (Nanjing, Jiangsu) |
| Status | Recruiting |
| Started | November 19, 2024 |
| Main results expected | March 31, 2027 |
| Study ends | March 31, 2028 |
| Registry record updated | December 20, 2024 |
| Trial ID | NCT06361238 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are elderly patients aged 60 and above with Type 2 diabetes who are scheduled for elective cardiac surgery.
✕Probably not a fit
Patients with a history of neurological or psychiatric disorders, severe liver dysfunction, or those who are pregnant or breastfeeding may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of liraglutide, a medication commonly used for Type 2 diabetes, in preventing postoperative delirium in elderly patients undergoing cardiac surgery. Delirium is a significant complication that can lead to increased mortality and longer hospital stays. The trial will compare the effects of liraglutide injections against placebo injections in this patient population. By targeting neuroinflammation, the study aims to reduce the incidence of delirium and improve postoperative outcomes.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce the occurrence of delirium in elderly diabetic patients after cardiac surgery, leading to better recovery and lower healthcare costs.
How similar studies have gone: Preliminary studies have shown promise for similar approaches, but this specific application of liraglutide in preventing postoperative delirium is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 60 years 2. Type 2 diabetes 3. Patients undergoing elective cardiac surgery Exclusion Criteria: 1. History of neurological or psychiatric disorders, such as schizophrenia, epilepsy, Parkinson's disease, severe dementia, etc 2. Patients with communication difficulties, such as severe visual, auditory, or speech impairments 3. History of central nervous system damage or surgery 4. Cardiac function NYHA Class IV 5. Severe liver dysfunction (Child-Pugh Class C) 6. Severe renal failure requiring renal replacement therapy 7. History of pancreatitis 8. Type 1 diabetes 9. Patients whose blood sugar is difficult to control within 4-8 mmol/L during the screening period 10. Patients with medullary thyroid carcinoma or a family history of it 11. Pregnant or breastfeeding women 12. Intolerance or allergy to liraglutide 13. Previous use of GLP-1A and SGLT2i 14. Patients who refuse to sign the informed consent
Where it's running
-
Wenxue liu
Nanjing, Jiangsu, China Recruiting
Study contacts
- Principal investigator: Dongjin Wang, PhD,MD — Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
- Study coordinator: Wenxue Liu, PhD,MD
- Email: diligent_hi@163.com
- Phone: 15751866806
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Personalized iPad audio messages to reduce confusion after hip fracture surgery
This trial will try 2-minute personalized audio reorientation messages on an iPad to see if they help prevent confusion (delirium) in people aged 60 and over after hip fracture surgery.
-
Impact of Fast-Track Anesthesia on Postoperative Delirium After Cardiac Surgery
This observational study tests whether fast-track anesthesia, compared with conventional care, is linked to lower rates of delirium after elective cardiac surgery in adults.
-
Remimazolam vs. Propofol for Sedation After Cardiac Surgery in Older Adults
This trial tests whether remimazolam tosylate can lower the rate of postoperative delirium compared with propofol in patients 65 and older after cardiac surgery with bypass.
-
Dexmedetomidine to See if Delirium Drops After Hip Fracture Surgery
This observational study tests whether using dexmedetomidine around hip fracture surgery helps prevent postoperative delirium in adults 65 and older.
-
How different pain control methods affect early mobilization after major surgery in older ICU patients
In this real-world study, researchers will observe how pain-relief methods used after major surgery in adults 65 and older in the ICU relate to how quickly they get out of bed and start moving.
-
VR-based cognitive games to help prevent delirium after big surgery
A VR-based cognitive stimulation game is being tested to see if it can help prevent delirium in adults 65 and older after major surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.